Ticker: ALNY

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is witnessing several developments as outlined in its latest quarterly income statement for the period ending March 31, 2025. Here’s a concise overview of the company's financial performance, highlighting key positives and negatives: Positive Aspects: ...

Pfizer (NYSE: PFE) stock has faced a significant dip, dropping over 50% since late 2021. Despite this, the company remains a strong dividend performer, boasting a 6.1% yield. With strategic acquisitions and robust new drug approvals, Pfizer projects adjusted earnings of $2.15-$2.35 per share for ...